1. The ‘current state of play’ in transplantation and restoration research of the CNS

   • David J. Eve
   • Paul R. Sanberg

   Commentary Pages: 145 - 150

2. The 6-Hydroxydopamine model of parkinson’s disease

   • Nicola Simola
   • Micaela Morelli
   • Anna R. Carta

   OriginalPaper Pages: 151 - 167

3. Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins

   • Mario Herrera-Marschitz
   • Diego Bustamante
   • Michel Goiny

   OriginalPaper Pages: 169 - 182

4. Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms

   • Jean Lud Cadet
   • Irina N. Krasnova
   • Johnalyn Lyles

   OriginalPaper Pages: 183 - 202

5. Glutamate antagonists are neurotoxins for the developing brain

   • Angela M. Kaindl
   • Chrysanthy Ikonomidou

   OriginalPaper Pages: 203 - 218

6. Model fusion: The next phase in developing animal models for parkinson’s disease

   • Amy B. Manning-BoĞ
   • J. William Langston

   OriginalPaper Pages: 219 - 240

7. Neurobehavioural and molecular changes induced by methylmercury exposure during development

   • Carolina Johansson
   • Anna F. Castoldi
   • Sandra Ceccatelli

   OriginalPaper Pages: 241 - 260

8. The blood-brain barrier for catecholamines — Revisited

   • Richard M. Kostrzewa

   Historical Paper Pages: 261 - 271